ENST00000676826.2:c.1188_1196dupTGCAGCCCC
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 2P and 10B. PM4BP6_ModerateBS1BS2
The ENST00000676826.2(GNAS):c.1188_1196dupTGCAGCCCC(p.Pro399_Ala400insAlaAlaPro) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00138 in 1,576,028 control chromosomes in the GnomAD database, including 21 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0070 ( 9 hom., cov: 33)
Exomes 𝑓: 0.00077 ( 12 hom. )
Consequence
GNAS
ENST00000676826.2 disruptive_inframe_insertion
ENST00000676826.2 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.26
Publications
1 publications found
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
GNAS-AS1 (HGNC:24872): (GNAS antisense RNA 1) This gene produces a paternally-imprinted antisense RNA transcript that helps regulate the GNAS complex locus, which encodes the alpha subunit of the stimulatory G protein. Defects in this gene are a cause of pseudohypoparathyroidism type Ib.[provided by RefSeq, Jun 2010]
GNAS-AS1 Gene-Disease associations (from GenCC):
- pseudohypoparathyroidism type 1BInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in ENST00000676826.2.
BP6
Variant 20-58854444-G-GGCAGCCCCT is Benign according to our data. Variant chr20-58854444-G-GGCAGCCCCT is described in ClinVar as Benign. ClinVar VariationId is 134477.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00705 (1072/152082) while in subpopulation AFR AF = 0.0242 (1004/41494). AF 95% confidence interval is 0.023. There are 9 homozygotes in GnomAd4. There are 495 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1072 AD,Mitochondrial,Unknown gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GNAS | ENST00000676826.2 | c.1188_1196dupTGCAGCCCC | p.Pro399_Ala400insAlaAlaPro | disruptive_inframe_insertion | Exon 1 of 13 | ENSP00000504675.2 | ||||
| GNAS | ENST00000371102.8 | c.1188_1196dupTGCAGCCCC | p.Pro399_Ala400insAlaAlaPro | disruptive_inframe_insertion | Exon 1 of 12 | 5 | ENSP00000360143.4 | |||
| GNAS | ENST00000371075.7 | c.*42+13567_*42+13575dupTGCAGCCCC | intron_variant | Intron 1 of 12 | 1 | NM_016592.5 | ENSP00000360115.3 | |||
| GNAS | ENST00000663479.2 | c.-39+12578_-39+12586dupTGCAGCCCC | intron_variant | Intron 1 of 12 | ENSP00000499353.2 | |||||
| GNAS | ENST00000462499.6 | c.-39+12578_-39+12586dupTGCAGCCCC | intron_variant | Intron 1 of 11 | 2 | ENSP00000499758.2 | ||||
| GNAS | ENST00000467227.6 | c.-39+10379_-39+10387dupTGCAGCCCC | intron_variant | Intron 2 of 12 | 3 | ENSP00000499681.2 | ||||
| GNAS | ENST00000453292.7 | c.*42+13567_*42+13575dupTGCAGCCCC | intron_variant | Intron 1 of 11 | 5 | ENSP00000392000.2 |
Frequencies
GnomAD3 genomes AF: 0.00704 AC: 1070AN: 151964Hom.: 9 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1070
AN:
151964
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00122 AC: 224AN: 183804 AF XY: 0.000973 show subpopulations
GnomAD2 exomes
AF:
AC:
224
AN:
183804
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000770 AC: 1097AN: 1423946Hom.: 12 Cov.: 34 AF XY: 0.000680 AC XY: 480AN XY: 705462 show subpopulations
GnomAD4 exome
AF:
AC:
1097
AN:
1423946
Hom.:
Cov.:
34
AF XY:
AC XY:
480
AN XY:
705462
show subpopulations
African (AFR)
AF:
AC:
800
AN:
32180
American (AMR)
AF:
AC:
47
AN:
39452
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25560
East Asian (EAS)
AF:
AC:
0
AN:
36938
South Asian (SAS)
AF:
AC:
0
AN:
81790
European-Finnish (FIN)
AF:
AC:
0
AN:
47994
Middle Eastern (MID)
AF:
AC:
7
AN:
5718
European-Non Finnish (NFE)
AF:
AC:
132
AN:
1095246
Other (OTH)
AF:
AC:
111
AN:
59068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
60
120
180
240
300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00705 AC: 1072AN: 152082Hom.: 9 Cov.: 33 AF XY: 0.00666 AC XY: 495AN XY: 74370 show subpopulations
GnomAD4 genome
AF:
AC:
1072
AN:
152082
Hom.:
Cov.:
33
AF XY:
AC XY:
495
AN XY:
74370
show subpopulations
African (AFR)
AF:
AC:
1004
AN:
41494
American (AMR)
AF:
AC:
36
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5134
South Asian (SAS)
AF:
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
17
AN:
67936
Other (OTH)
AF:
AC:
15
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
6
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:2Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.